InvestorsHub Logo
Followers 79
Posts 24601
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 03/19/2024 7:20:26 AM

Tuesday, March 19, 2024 7:20:26 AM

Post# of 27514
CATX - .965 Pre-market at 1.21/1.22

Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.